Risks factors for pediatric malignant liver tumors;Factores de riesgo para los tumores hepáticos malignos pediátricos

Anales de Pediatria

Volumn 68, Issue 4, 2008, Pages 377-384

  Ferris I Tortajada J ^a   Ortega Garcia J A ^b   Garcia I Castell, J ^c   Lopez Andreu J A ^d   Ribes Koninckx, C ^d   Berbel Tornero, O ^e  

^a HOSPITAL INFANTIL LA FE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c HOSPITAL DE SAGUNTO   (Spain)

^d Hospital Infantil Universitario La Fe

^e Centro de Salud Nazaret   (Spain)

Author keywords

Hepatitis B virus; Hepatitis C virus; Hepatoblastoma; Hepatocarcinoma; Pediatric Hepatic Malignancies; Risk factors

Indexed keywords

ALCOHOL; ARSENIC; PESTICIDE; VINYL CHLORIDE;

ARTICLE; BECKWITH WIEDEMANN SYNDROME; COLON POLYP; FATTY LIVER; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATOBLASTOMA; HORMONAL THERAPY; HUMAN; IONIZING RADIATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HYPERPLASIA; LIVER TUMOR; OCCUPATIONAL EXPOSURE; RISK FACTOR; SCLEROSING CHOLANGITIS; SMOKING; TREMATODE; VACCINATION; VERY LOW BIRTH WEIGHT;

EID: 42149108014     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1157/13117711     Document Type: Article

References (56)

1. Mueller BU, López-Terrada D, Finegold MJ. Tumors of the Liver. En: Pizzo PA, Poplack DG, editors. Principle and practice of pediatric oncology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 887-904.
2. Stiller CA, Pritchard J, Stelianova-Foucher E. Liver cancer in European children: Incidence and survival 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2115-23.
3. Kramárová E, Stiller CA, Ferlay J, Parkin DM, Draper GJ, Michaelis J, et al. International Classification of Childhood Cancer. IARC Technical Report No. 29. Lyon: International Agency for Research on Cancer; 1996.
4. Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, et al, editors. Cancer incidence and survival among children and adolescents. Bethesda: United States SEER Program 1975-1995; 1999.
5. Little J. Epidemiology of Childhood Cancer. IARC Scientific Publications No. 149. Lyon: International Agency for Research on Cancer; 1999.
6. Loffredo C, Frank C. Liver cancer: Risk factors and prevention. En: Shields PG, editor. Cancer risk assessment. 1st ed. Boca Raton: Taylor & Francis Group; 2005. p. 621-46.
7. Stuver S, Trichopoulos D. Cancer of the Liver and Biliary Tract. En: Adami HO, Hunter D, Trichopoulos D, editors. Textbook of cancer epidemiology. 1st ed. New York: Oxford University Press; 2002. p. 212-32.
8. Darbari A, Sabin KM, Shapiro CN, Schwartz KB. Epidemiology of primary hepatic malignancies. Hepatology. 2003;38:560-6.
9. Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology. 2004;127:572-8.
10. London WT, McGlynn KA. Liver Cancer. En: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006. p. 763-86.
11. Ross JA, Swensen AR. Prenatal epidemiology of pediatric tumors. Curr Oncol Rep. 2000;2:234-41.
12. Nomura T. Transgenerational carcinogenesis: Induction and transmission of genetic alterations and mechanisms of carcinogenesis. Mutation Res. 2003;544:425-32.
13. Ferrís i Tortajada J, Ortega García JA, Marco Macián A, García I, Castell J. Medio ambiente y cáncer pediátrico. An Pediatr (Barc). 2004;61:42-50.
14. Plon SE, Nathanson K. Inherited susceptibility for pediatric cancer. Cancer J. 2005;11:255-67.
15. Lapunzina Badía P, Del Campo Casanelles M, Delicado Navarro A, Fernández Toral J, García-Alix A, García Guereta L, et al. Guía clínica para el seguimiento de pacientes con síndrome de Beckwith-Wiedemann. An Pediatr (Barc). 2006;64:252-9.
16. De Baum MR, Tucker MA. Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr. 1998;132:398-400.
17. Tan TY, Amor DJ. Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: A critical review of the evidence and suggested guidelines for local practice. J Paeditr Child Health. 2006;42:486-90.
18. Lapunzina P. Risk of tumorigenesis in overgrowth syndromes: A comprehensive review. Am J Med Genet C Semin Genet. 2005;137:53-71.
19. Giardiello FM, Petersen GM, Brensinger JD, Luce MC, Cayouette MC, Bacon J, et al. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut. 1996;39:867-400.
20. Morcos M, Dubois S, Bralet MP, Belghiti J, Degott C, Terris B. Primary liver cancer in genetic hemochromtosis reveals a broad histologic spectrum. Am J Clin Pathol. 2001;116:738-43.
21. Perlmutter DH. Alpha-1-antitypsin deficiency. Semin Liver Dis. 1998;18:217-25.
22. Linet MS, Gridley G, Nyren O, Mellemkjaer L, Olsen JH, Keehn S, et al. Primary liver cancer, other malignancies, and mortality risks following porphyria: A cohort study in Denmark and Sweden. Am J Epidemiol. 1999;149:1010-5.
23. Sorensen HT, Friis S, Olsen JH, Thulstrup AM, Linet M, Trichopoulos D, et al. Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark. Hepatology 1998;28:921-5.
24. Zen Y, Katayanagi K, Tsuneyama K, Harada K, Araki I, Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int. 2001;51:127-31.
25. Harnois DM, Gores GJ, Ludwig J, Steers JL, Larusso NF, Wiesner PH. Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? J Hepatol. 1997;27:512-6.
26. Swinney R, Hsu S, Tomlinson G. Phase I and phase II polymorphisms and childhood cancer. J Invest Med. 2006;54:303-20.
27. Parkin DM, Muir ES, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer incidence in five continents. Volume VII. International Agency for Research on Cancer. Scientific Publications no. 120. Lyon: IARC Press; 1992.
28. Bunin GR. Nongenetic causes of childhood cancers: Evidence from international variation, time trends, and risk factor studies. Toxicol Appl Pharmacol. 2004;199:91-103.
29. Lupberger J, Hildt E. Hepatitis B virus-induced oncogenesis. World J Gastroenterol. 2007;13:74-81.
30. Howley PM, Canem D, Kief E. Etiology of Cancer: Viruses. 2. DNA Viruses. En: De Vita VT Jr, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 158-77.
31. Hansen HV, editor. Infections causing human cancer. 1st ed. Weinheim: Wiley-VCH; 2006.
32. Bialek SR, Terrault NA. The changing epidemiology and natural history of hepatitis C virus infection. Clin Liver Dis. 2006;10:697-715.
33. Poeschla EM, Buchschacher Jr GL, Wong-Staal F. Etiology of Cancer: Viruses. 1. RNA Viruses. En: De Vita VT Jr, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 149-58.
34. Sung MW, Thung SN. Hepatitis Viruses. En: Kufe DW, Bast RC Jr, Hait WN, Hong WK, Pollock RE, Weichselbaum RR, et al, editors. Cancer medicine. 7th ed. Hamilton: BC Decker Inc.; 2006. p. 323-31.
35. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infection in causing hepatocellular carcinoma. Int J Cancer. 1998;75:347-54.
36. Wild CP, Turner PC. The toxicology of aflatoxins as a basis for public health decisions. Mutagenesis. 2002;17:471-81.
37. Wogan GN. Aflatoxins as risk factor for hepatocellular carcinoma in humans. Cancer Res. 1992;52:2114s-2118s.
38. Kew MC. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver Int. 2003;23:405-9.
39. Mori M, Hara M, Wada I, Hara T, Yamamoto K, Honda M, et al. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol. 2000;15:131-9.
40. Travis LB, Kathren RL, Boice JD. Cancer risk following exposure to Thorotrast: Overview in relation to a case report. Health Phys. 1992;63:89-97.
41. Lipshutz GS, Brennan TV, Warren RS. Thorotrast induced liver neoplasia: A collective review. J Am Coll Surg. 2002;195:713-8.
42. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, et al. Cancer incidence in atomic bomb survivors. Part II: Solid tumors 1958-1987. Radiat Res. 1994;137 Suppl 2:S17-67.
43. Cologne JB, Tokuoka S, Beebe GW, Fukuhara T, Mabuchi K. Effects of radiation on incidence of primary liver cancer among atomic bomb survivors. Radiation Res. 1999;152:364-73.
44. McKillop IH, Schrum LW. Alcohol and liver cancer. Alcohol. 2005;35:195-203.
45. Voigt MD. Alcohol in hepatocellular cancer. Clin Liver Dis. 2005;9:151-69.
46. Seitz HK, Stickel F. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem. 2006;387:349-60.
47. Giannitrapani L, Soresi M, La Spada E, Cervello M, D'Alessandro N, Montalto G. Sex hormones and risk of liver tumor. Ann N Y Acad Sci. 2006;1089:228-36.
48. De Maria N, Manno M, Villa E. Sex hormones and liver cancer. Mol Cell Endocrinol. 2002;193:59-63.
49. Coleman WB. Mechanisms of human hepatocarcinogenesis. Curr Mol Med. 2003;3:573-88.
50. Berbel Tornero O, Ferrís i Tortajada J, Donat Colomer J, Ortega García JA, Verdeguer Miralles A. Factores de riesgo asociados a los tumores neonatales. Experiencia de una unidad de salud medioambiental pediátrica (PEHSU-Valencia). An Pediatr (Barc). 2006;64:439-48.
51. El-Zayadi AR. Heavy smoking and liver. World J Gastroenterol. 2006;12:6098-101.
52. McLaughlin CC, Baptiste MS, Schymura MJ, Nasca PC, Zdeb MS. Maternal and infant birth characteristics and hepatoblastoma. Am J Epidemiol. 2006;163:818-28.
53. International Agency for Research on Cancer. Schistosomas, liver flukes and helicobacter pylori. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 61. Lyon: IARC Press, 1994.
54. Fecht WJ Jr, Befeler AS. Hepatocellular carcinoma: Updates in primary prevention. Curr Gastroenterol Rep. 2004;6:37-43.
55. Kensler TW, Egner PA, Wang JB, Zhu YR, Zhang BC, Qian GS, et al. Strategies for chemoprevention of liver cancer. Eur J Cancer Prev. 2002;11 Suppl 2:S58-64.
56. Yu SZ. Primary prevention of hepatocellular carcinoma. J Gastroenterol Hepatol. 1995;10:674-82.